Issues and Controversies in the Diagnosis and Management of Bipolar Disorder: Focus on Bipolar I and
Location: United States
|Event Date/Time: Jun 18, 2009||End Date/Time: Jun 18, 2009|
Bipolar disorder (BD) is a chronic, recurring illness characterized by episodes of depression alternating with periods of mania or hypomania. It is associated with significant impairments in global functioning, inter-episodic morbidity, decreased quality of life, and a substantially increased risk of suicide. The lifetime prevalence of bipolar disorder is estimated at 3.9%, if a broad definition of bipolar disorder is used (bipolar I with mania, bipolar II with hypomania, and subthreshold bipolar disorder).
In order for clinicians to provide the best treatment for patients with BD, it is essential that they accurately diagnose the condition and understand the evidence, complexity, and controversy regarding pharmacologic treatment strategies. They must also appreciate the factors that worsen the long-term course of the illness, such as medication non-adherence and co-morbid medical and psychiatric conditions, and must understand the treatments, such as intensive psychotherapy, that may speed recovery and help sustain wellness.